These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 28265267)
41. 2'-Fucosyllactose Inhibits Human Norovirus Replication in Human Intestinal Enteroids. Patil K; Ayyar BV; Neill FH; Bode L; Estes MK; Atmar RL; Ramani S bioRxiv; 2024 May; ():. PubMed ID: 38853945 [TBL] [Abstract][Full Text] [Related]
42. Soluble extracellular polymeric substance (SEPS) of histo-blood group antigen (HBGA) expressing bacterium Sphingobacterium sp. SC015 influences the survival and persistence of norovirus on lettuce. Liao N; Tang M; Chen L; Tian P; Wang D; Cheng D; Wu G Food Microbiol; 2023 Feb; 109():104126. PubMed ID: 36309436 [TBL] [Abstract][Full Text] [Related]
43. Inactivation conditions for human norovirus measured by an in situ capture-qRT-PCR method. Wang D; Tian P Int J Food Microbiol; 2014 Feb; 172():76-82. PubMed ID: 24361836 [TBL] [Abstract][Full Text] [Related]
44. A quantitative exposure model simulating human norovirus transmission during preparation of deli sandwiches. Stals A; Jacxsens L; Baert L; Van Coillie E; Uyttendaele M Int J Food Microbiol; 2015 Mar; 196():126-36. PubMed ID: 25544470 [TBL] [Abstract][Full Text] [Related]
45. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects. Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444 [TBL] [Abstract][Full Text] [Related]
46. Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein. Zhu Y; Ma Y; Lu M; Zhang Y; Li A; Liang X; Li J Viruses; 2019 May; 11(5):. PubMed ID: 31100802 [TBL] [Abstract][Full Text] [Related]
47. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens. Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559 [TBL] [Abstract][Full Text] [Related]
48. Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition. Tenge V; Vijayalakshmi Ayyar B; Ettayebi K; Crawford SE; Shen YT; Neill FH; Atmar RL; Estes MK bioRxiv; 2024 Jan; ():. PubMed ID: 38260626 [TBL] [Abstract][Full Text] [Related]
49. The influence of temperature, pH, and water immersion on the high hydrostatic pressure inactivation of GI.1 and GII.4 human noroviruses. Li X; Chen H; Kingsley DH Int J Food Microbiol; 2013 Oct; 167(2):138-43. PubMed ID: 24135670 [TBL] [Abstract][Full Text] [Related]
50. Infectivity of GII.4 human norovirus does not differ between T-B-NK Annamalai T; Lu Z; Jung K; Langel SN; Tuggle CK; Dekkers JCM; Waide EH; Kandasamy S; Saif LJ Virus Res; 2019 Jul; 267():21-25. PubMed ID: 31054932 [TBL] [Abstract][Full Text] [Related]
51. Human norovirus inhibition by a human milk oligosaccharide. Koromyslova A; Tripathi S; Morozov V; Schroten H; Hansman GS Virology; 2017 Aug; 508():81-89. PubMed ID: 28505592 [TBL] [Abstract][Full Text] [Related]
52. Binding of Li Q; Wang D; Yang D; Shan L; Tian P Front Microbiol; 2017; 8():1746. PubMed ID: 28983282 [TBL] [Abstract][Full Text] [Related]
53. Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response. Qu L; Murakami K; Broughman JR; Lay MK; Guix S; Tenge VR; Atmar RL; Estes MK J Virol; 2016 Oct; 90(19):8906-23. PubMed ID: 27466422 [TBL] [Abstract][Full Text] [Related]
54. A Luciferase Immunoprecipitation System (LIPS) assay for profiling human norovirus antibodies. Tin CM; Yuan L; Dexter RJ; Parra GI; Bui T; Green KY; Sosnovtsev SV J Virol Methods; 2017 Oct; 248():116-129. PubMed ID: 28673856 [TBL] [Abstract][Full Text] [Related]
55. Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. Cheetham S; Souza M; Meulia T; Grimes S; Han MG; Saif LJ J Virol; 2006 Nov; 80(21):10372-81. PubMed ID: 17041218 [TBL] [Abstract][Full Text] [Related]
56. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains. Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312 [TBL] [Abstract][Full Text] [Related]
57. Estimation of Human Norovirus Infectivity from Environmental Water Samples by In Situ Capture RT-qPCR Method. Tian P; Yang D; Shan L; Li Q; Liu D; Wang D Food Environ Virol; 2018 Mar; 10(1):29-38. PubMed ID: 28856596 [TBL] [Abstract][Full Text] [Related]
58. Epidemiological Impact of GII.17 Human Noroviruses Associated With Attachment to Enterocytes. Estienney M; Tarris G; Abou-Hamad N; Rouleau A; Boireau W; Chassagnon R; Ayouni S; Daval-Frerot P; Martin L; Bouyer F; Le Pendu J; de Rougemont A; Belliot G Front Microbiol; 2022; 13():858245. PubMed ID: 35572680 [TBL] [Abstract][Full Text] [Related]
59. Immunogenicity and Blocking Efficacy of Norovirus GII.4 Recombinant P Protein Vaccine. Yu Z; Shao Q; Xu Z; Chen C; Li M; Jiang Y; Cheng D Vaccines (Basel); 2023 Jun; 11(6):. PubMed ID: 37376442 [TBL] [Abstract][Full Text] [Related]
60. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China. Huo Y; Zheng L; Chen X; Ge L; Wang Y Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]